Domain Associates, LLC

Portfolio Companies (Former)

		3F Therapeutics, Inc. Devices to treat heart valve disorders Acquired by ATS Medical, Inc.

		Acureon Pharmaceuticals, Inc. Acquire and market drugs focused on infectious diseases, transplant and ICU

		Aesthetic Sciences Corporation Focused on aesthetic medicine and incontinence
Aesthetic Sciences Corporation

		Align Technology, Inc. Invisalign® invisible braces

		Amylin Pharmaceuticals, Inc. Development of drugs to treat metabolic diseases

		Ansata Therapeutics, Inc. Drug development utilizing cell targeting technology

		Applied Molecular Evolution, Inc. Gene evolution technology to optimize proteins for drug and industrial use Acquired by Eli Lilly & Co.
Applied Molecular Evolution, Inc.

		Athena Neurosciences, Inc. Development of diagnostics and therapeutics for Alzheimer's Disease Acquired by Elan Corporation
Athena Neurosciences, Inc.

		AtheroGenics, Inc. Discovery and development of drugs for inflammatory diseases

		Aurora Biosciences Corporation Automation to facilitate drug discovery processes Acquired by Vertex Pharmaceuticals
Aurora Biosciences Corporation

		Auxeris Therapeutics, Inc. Osteoporosis drug development

		Biomagnetic Technologies Inc. Instrumentation for ultra-sensitive magnetic measurement
Biomagnetic Technologies Inc.

		Biosite Diagnostics, Inc. Discovery, development and marketing of rapid diagnostics

		BiPar Sciences, Inc. Developing and commercializing potential new classes of tumor-selective drugs Acquired by Sanofi-aventis

		British Biotech Diversified life-sciences company developing both drugs and research products Merged with Vernalis pls
British Biotech

		Cabrellis Pharmaceuticals Corporation Development of important therapies for the treatment of cancer Acquired by Pharmion Corporation

		Cadent Medical Corporation Life-saving external defibrillators Acquired by Cardiac Science, Inc.
Cadent Medical Corporation

		Calixa Therapeutics, Inc. Focused on developing, acquiring and commercializing hospital-based anti-infective therapies Acquired by Cubist Pharmaceuticals, Inc.

		Cardiac Science Corporation Life-saving external defibrillators

		CardioDynamics International Corporation Noninvasive digital heart monitoring devices

		CardioPolymers, Inc. Novel therapies for diseases of cardiac conduction Merged with Lonestar Heart, Inc.

		CareCentric Solutions, Inc. Information systems for the home care industry Acquired by Simione Central Holdings, renamed Care Centric

		Celladon Corporation Developing treatments for cardiovascular diseases through molecular cardiology

		Cerexa, Inc. Focused on developing, acquiring and commercializing hospital-based anti-infective therapies Acquired by Forest Laboratories, Inc.

		Ciblex Corporation Development of drugs that impact protein trafficking for use in proliferative disorders

		CoCensys, Inc. Development of CNS drugs targeted at novel CNS receptors Acquired by Purdue Pharma
CoCensys, Inc.

		Conforma Therapeutics Corporation Anti-cancer drug development Acquired by Biogen IDEC

		Connetics Corporation Development and marketing of dermatology drugs Acquired by Stiefel Laboratories, Inc.

		Corthera, Inc. Development of Relaxin for various indications Acquired by Novartis Pharmaceuticals Corporation

		Cortria Corporation Developing safe and well-tolerated medicines to fight cardiovascular disease Acquired by Pharmena SA

		Creative Biomolecules, Inc. Development of regenerative medicines Merged into Curis, Inc.
Creative Biomolecules, Inc.

		Cytovia, Inc. Drug screening technology using proprietary apoptosis assays Acquired by Maxim Pharmaceuticals, Inc.
Cytovia, Inc.

		DiObex, Inc. Development of drugs to improve the management of diabetic patients

		DNX Corporation Development of in vitro and in vivo biological models Merged with BioClin to form Chrysalis International Corporation, subsequently acquired by Phoenix International Life Sciences, now part of MDS Pharma
DNX Corporation

		Domain AntiBacterial Acquisition Corporation In-licensing of anti-infective drugs Acquired by Peninsula Pharmaceuticals, Inc.
Domain AntiBacterial Acquisition Corporation

		Dura Pharmaceuticals, Inc. Specialty pharmaceutical company focused on respiratory drugs Acquired by Elan Corporation
Dura Pharmaceuticals, Inc.

		Embrex, Inc. Unique delivery system for poultry vaccines and therapeutics Acquired by Pfizer Animal Health

		ESP Pharma, Inc. Acquires & markets acute care products Acquired by Protein Design Labs, Inc.

		Esprit Pharma, Inc. Acquisition, development and marketing of drugs for the urology and OB-GYN physician communities Acquired by Allergan, Inc.

		Eunoe, Inc. Device to treat Alzheimer's disease

		Exelixis, Inc. Genomics-based drug discovery

		Focal, Inc. Biodegradable materials for the prevention of surgical adhesions Acquired by Genzyme BioSurgery
Focal, Inc.

		Fusion Medical Technologies, Inc. Biomaterial for use in surgical procedures to prevent adhesions Acquired by Baxter Healthcare Corporation
Fusion Medical Technologies, Inc.

		GelTex Pharmaceuticals, Inc. Polymer technology for drugs that stay in the GI tract and remove toxins Acquired by Genzyme
GelTex Pharmaceuticals, Inc.

		GeneOhm Sciences, Inc. Molecular diagnostics Acquired by Becton, Dickinson and Company

		GenQuest, Inc. Gene identification for diagnostic and therapeutic applications Acquired by Corixa Corporation
GenQuest, Inc.

		Gensia Pharmaceuticals Inc. Development of drugs to treat cardiovascular diseases Merged into Sicor; Sicor since acquired by Teva Pharmaceuticals
Gensia Pharmaceuticals Inc.

		Genta Incorporated Development of antisense therapeutics

		Geron Corporation Discovery of mechanisms and therapeutics that impact the aging process

		GlycoDesign Development of novel therapeutics for treatment of cancer, infectious diseases and inflammation Acquired by Inflazyme
GlycoDesign

		Gynecare, Inc. Medical devices for women's healthcare Acquired by Johnson & Johnson

		Helixis, Inc. Developing a molecular diagnostic testing platform for use in diverse physical locations Acquired by Illumina, Inc.

		Imagine Pharmaceuticals, Inc. Technology to facilitate delivery of drugs to the brain

		Imagyn Medical, Inc. Medical devices for gynecological indications Acquired by UroHealth, renamed Imagyn Medical Technologies, Inc.
Imagyn Medical, Inc.

		Immune Control, Inc. Developing drugs to stop undesirable proliferation of immune cells Merged with Corridor Pharmaceuticals, Inc.

		Inspire Pharmaceuticals, Inc. Drug development for ophthalmic and respiratory diseases

		IntraLase Corporation Devices for laser correction of vision Acquired by Advanced Medical Optics, Inc., since acquired by Abbott Laboratories

		Iomai Corporation Transdermal vaccines

		Ista Pharmaceuticals, Inc. Drug development for ophthalmic diseases

		Konova, Inc. Anti-obesity drug development
Konova, Inc.

		LaJolla Pharmaceutical Company Development of therapeutics for antibody-related disorders

		Landec Corporation Crystallizable polymers for a variety of medical and industrial applications

		Lumisys, Inc. High-performance electro-optical systems for medical imaging Acquired by Eastman Kodak

		Microgon Inc. Hollow-fiber membrane filters for use in research laboratories Acquired by Spectrum Laboratories
Microgon Inc.

		Microsurge Improved instrumentation for minimally invasive surgery Acquired by UroHealth, renamed Imagyn Medical Technologies, Inc.
Microsurge

		MicroVention, Inc. Interventional neurology devices Acquired by Terumo Corporation

		MIGENIX Inc. Development of drugs for the prevention and treatment of infectious diseases

		MitoKor Discovery and development of drugs for mitochondrial diseases Acquired by Micrologix Biotech Inc. (now MIGENIX Inc.)

		Molecular Dynamics Use of optical technology to automate laboratory processes Acquired by Amersham Pharmacia Biotech
Molecular Dynamics

		Molecular Staging, Inc. Biomarker discovery utilizing novel DNA/RNA amplification technology

		Neose Technologies, Inc. Enhancement of drugs by glcyosylation Assets sold to Novo Nordisk & BioGeneriX

		Northstar Neuroscience, Inc. Electrical stimulation to treat neurological defects

		NovaCardia, Inc. Cardiovascular drug development Acquired by Merck & Co., Inc.

		Novacea, Inc. Anti-cancer drug development Merged into Transcept Pharmaceuticals, Inc.

		NPS Pharmaceuticals, Inc. Development of drugs for bone, GI, and CNS diseases

		NuVasive, Inc. Devices to assist in spinal surgery

		Oceana Therapeutics, Inc. Acquire and market drugs

		OmniSonics Medical Technologies, Inc. Device to remove vascular occlusions

		OncoTherapeutics Cancer diagnostics and therapeutics based on Kallikrein family of proteins Acquired by Biomira Inc.
OncoTherapeutics

		Onux Medical, Inc. Minimally invasive surgical tools Acquired by Davol, Inc., a subsidiary of C.R. Bard, Inc.

		Onyx Pharmaceuticals, Inc. Anti-cancer drug development

		OraPharma, Inc. Development of dental medications Acquired by Johnson & Johnson

		Origin Medsystems Inc. Instruments and devices for minimally invasive surgery Acquired by Eli Lilly, subsequently spun-out as Guidant
Origin Medsystems Inc.

		Orqis Medical Corporation Device to treat congestive heart failure

		Peninsula Pharmaceuticals, Inc. Anti-infective drug development Acquired by Johnson & Johnson

		Pharmion Corporation Acquires and markets hematology products Acquired by Celgene Corporation

		Pointshare Corporation Community-based healthcare intra and extranet solutions

		Proxima Therapeutics, Inc. Novel system to deliver radiation to treat cancer Acquired by Cytyc Corporation

		Receptor BioLogix, Inc. Developing a new class of protein therapeutics called Intron Fusion Proteins

		Resound Corporation Revolutionary technology for hearing aids Merged into GN ReSound

		RiboGene, Inc. Therapeutics based on control of protein translation Merged with Cypros to form Questcor
RiboGene, Inc.

		Ruxton Pharmaceuticals, Inc. Proprietary assays to discover and develop drugs to treat ALS

		Santarus, Inc. GI drug development using novel formulations

		Selective Genetics, Inc. Site-specific gene therapies primarily for tissue repair

		Senomyx, Inc. Discovery and development of flavor enhancing chemicals

		SenoRx, Inc. Surgical tools for breast disease

		Sepracor, Inc. Separation technology applied to drug discovery

		Sievers Instruments, Inc. Novel detectors for gas chromatography Acquired by Ionics
Sievers Instruments, Inc.

		Small Molecule Therapeutics, Inc. Discovery of small molecule drugs based on proprietary screening technology Acquired by MorphoChem AG

		Somaxon Pharmaceuticals, Inc. Development of psychiatric drugs

		Trega Biosciences, Inc. Combinatorial chemistry technology used to discover novel therapeutics Acquired by Lion bioscience
Trega Biosciences, Inc.

		Trimeris, Inc. Novel HIV therapeutics

		Univax Vaccines to stimulate the plasma donor production of immunoglobulins Acquired by Nabi Pharmaceuticals
Univax

		US Bioscience, Inc. Acquisition and marketing of cancer drugs Acquired by MedImmune

		Valley Forge Pharmaceuticals, Inc. Anti-myopia drug development

		Vanda Pharmaceuticals, Inc. Analysis of genetic, genomic and clinical date to rescue "failed" drugs

		Vascular Architects, Inc. Novel stent technology Acquired by LeMaitre Vascular

		Vascular Therapeutics, Inc. Biopharmaceuticals for the prevention and treatment of vascular disease Acquired by GlycoDesign, since acquired by Inflazyme
Vascular Therapeutics, Inc.

		VenPro Corporation Intravascular valve technology Acquired by 3F Therapeutics

		Verus Pharmaceuticals, Inc. Development and marketing of pediatric focused therapeutics

		Viagene Inc. Gene manipulation technology for the discovery of anti-infective therapies Acquired by Chiron
Viagene Inc.

		Vista Medical Technologies, Inc. Visualization technology to aid in surgical procedures

		Vivus, Inc. Therapeutics to treat sexual dysfunction

		Xcel Pharmaceuticals, Inc. Acquires & markets neurology products Acquired by Valeant Pharmaceuticals International

		X-Ceptor Therapeutics, Inc. Drug development focused on orphan nuclear receptors Acquired by Exelixis, Inc.